MedPath

Rituximab on Adult-onset frequenTly rElApsing or steroid dependent nephrotic syndrome study

Not Applicable
Conditions
adult-onset frequently relapsing or steroid dependent nephrotic syndrome
Registration Number
JPRN-UMIN000041475
Lead Sponsor
Osaka University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
72
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients with secondary nephrotic syndrome (including suspicion) 2. Patients who have been treated with rituximab 3.Patients with eGFR of 44mL / min / 1.73m2 or less 4.Patients with an infectious disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath